Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 22, 2024Virtual Press Office and PR Newswire: General Trade show news
Company unveils Parkinson's disease associated with GBA mutations (PD-GBA) program; two oral presentations feature new data from Capsida's wholly owned programs in PD-GBA and genetic epilepsy due...
-
Apr 22, 2024Virtual Press Office and PR Newswire: General Trade show news
Novel dual CAR approach is designed to enhance CAR T-cell activity in solid tumors by addressing immune suppression in the tumor microenvironment LOS ANGELES, April 22, 2024 /PRNewswire/ --...
-
Apr 22, 2024Virtual Press Office and PR Newswire: General Trade show news
Preclinical data highlights the potential of engineered macrophage cell therapy as a treatment for liver and lung fibrosis Novel Redirected Soluble Modulator technology has demonstrated the...
-
Apr 22, 2024Virtual Press Office and PR Newswire: General Trade show news
Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for rare and...
-
Apr 22, 2024Virtual Press Office and PR Newswire: General Trade show news
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease, and more, today announced...